Categories: AlphaGraphs

Infographic: Highlights of Altria Group’s (MO) Q3 earnings report

Tobacco giant Altria Group, Inc. (NYSE: MO) reported stronger-than-expected earnings and revenues for the third quarter of 2020. The company also issued earnings guidance for fiscal 2020. The stock gained modestly on Friday morning, after closing the previous session higher.

The company posted adjusted earnings of $1.19 per share for the September-quarter, unchanged from the prior-year period but slightly above analysts’ estimates. On an unadjusted basis, it was a net loss of $951 million or $0.51 per share, narrower than the $2.6 billion or $1.39 per share loss reported last year.

Revenues increased 3.9% annually to $7.12 billion in the third quarter of 2020, far exceeding the consensus forecast.


Read management/analysts’ comments on Altria’s Q3 results


“In the third quarter, our tobacco businesses delivered strong financial performance once again and we continued to make progress against our 10-year Vision,” said Altria’s CEO Billy Gifford.

Recent Posts

Aramark Holdings Q1 Revenue Tops Estimates; Shares Mixed After Close

Aramark Holdings Corp (NYSE: ARMK) shares closed at about $38.77 on Monday, marking a modest…

3 minutes ago

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

27 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

41 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

43 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

1 hour ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

1 hour ago